EHC vs HCA
EHC: Encompass Health is the nation’s leading provider of inpatient rehabilitation services, focused on improving patient outcomes through specialized, evidence-based care for complex neurological and physical recovery. HCA: HCA Healthcare is one of the nation's largest operators of acute care hospitals and related health services, leveraging a massive footprint to provide comprehensive medical care.
Side-by-side fundamentals
| Metric | EHC | HCA | Edge |
|---|---|---|---|
| Price as of 2026-10-20 close | $121.67 | $465.75 | |
| Market cap | $12.0B | $100.8B | |
| P/E as of 2026-10-20 | 19.82 | 16.04 | HCA lower |
| PEG as of 2026-10-20, 3-year EPS CAGR to FY2025 | 0.73 | 1.15 | EHC lower |
| Net margin FY2025, SEC XBRL | +9.5% | +9.0% | EHC higher |
| Operating margin FY2022, SEC XBRL | +12.4% | n/a | |
| ROE FY2025, SEC XBRL | +23.2% | n/a | |
| ROA FY2025, SEC XBRL | +8.0% | +11.2% | HCA higher |
| Debt / equity filed borrowings incl. finance leases, balance sheet 2026-06-30 | 1.01 | n/a | |
| Revenue growth (YoY) FY2025, SEC XBRL | +10.5% | +7.1% | EHC higher |
| Revenue CAGR (3y) SEC XBRL | +10.9% | +7.9% | EHC higher |
| Dividend yield as of 2026-09-03 | +0.7% | +0.7% | HCA higher |
| Dividend streak (yrs) SEC XBRL | 3 | 6 | HCA higher |
| Beta as of 2026-09-03 | 0.42 | 0.23 | |
| 1-year return as of 2026-10-20 close | -2.8% | +7.5% | HCA higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-20.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.